NEW YORK CITY—The investigational olanzapine-samidorphan drug ALKS 3831 did not outperform olanzapine alone in reducing alcohol use in patients with schizophrenia and alcohol use disorder, but it did improve symptoms of schizophrenia, a study found.
APA Annual Meeting
Is genetic testing in psychiatry a dangerous development or a useful addition to a clinician’s toolkit?
A small pilot study presented at the American Psychiatric Association’s annual meeting Monday suggests bifrontal transcranial magnetic stimulation (TMS) may be an effective treatment for chronic insomnia.
Certain 24-hour activity patterns were found to be associated with depressive symptoms in older men, in a study presented Sunday during a poster session at the American Psychiatric Association’s annual meeting.
he anticonvulsant topiramate significantly reduced hyperarousal symptoms in patients with post-traumatic stress disorder, according to a systematic review and meta-analysis presented Sunday during a poster session at the American Psychiatric Association’s annual meeting.
Cariprazine showed superior efficacy and good tolerability at both low and high doses, compared with placebo, in the treatment of patients with psychosis, mania, and depression, according to a systematic review.